Virax Biolabs Group Limited (VRAX)

0.6273 +0.0073 (+1.18%) At close: 04:00PM EDT

Virax Biolabs Group Limited

20 North Audley Street
London W1K 6LX
United Kingdom
44 20 7788 7414
https://viraxbiolabs.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 11

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. James Foster	Chairman & CEO	347.5k	N/A	1985
Mr. Jason D. Davis	Chief Financial Officer	237.5k	N/A	1972
Mr. Mark James Ternouth	Chief Technical Officer & Director	90k	N/A	1968
Dr. Tomasz Evan George	Chief Scientific Officer	194k	N/A	1984
Dr. Nigel McCracken M.Sc., Ph.D.	Chief Operating Officer	N/A	N/A	N/A
Ms. Joel Yeung	Accounting Manager	N/A	N/A	N/A
Mr. Clement Monteil	Head of Scientific Research & Development	N/A	N/A	N/A
Mr. James Wang	Head of Procurement & Sourcing	N/A	N/A	N/A
Ms. Lily Fu	Head of Supply Chain	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name. It also develops T-Cell IVD test kit for COVID-19, which intend to adapt for immunological profiling against multiple viral threats under the ViraxImmune Brand, as well as a proprietary mobile application for ViraxImmune that presents an individual's immunological profiling data and provide advice on the users' immune system. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, pharmaceutical companies, research institutions, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom.

Corporate Governance

Virax Biolabs Group Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.